Mercer Global Advisors Inc Incyte Corp Transaction History

Mercer Global Advisors Inc

$45.6 Billion
Q3 2024

A detailed history of Mercer Global Advisors Inc transactions in Incyte Corp stock. As of the latest transaction made, Mercer Global Advisors Inc holds 3,295 shares of INCY stock, worth $229,101. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,295

Holding current value

$229,101

% of portfolio

0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$57.33 - $68.61 $188,902 - $226,069	3,295 New	3,295 $217,000
Q3 2021 Nov 10, 2021	SELL	$68.67 - $84.02 $2.42 Million - $2.96 Million	-35,208 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$79.87 - $87.53 $1,038 - $1,137	13 Added 0.04%	35,208 $2.96 Million
Q1 2021 Aug 10, 2021	BUY	$76.02 - $100.5 $67,277 - $88,942	885 Added 2.58%	35,195 $2.86 Million
Q1 2021 May 11, 2021	SELL	$76.02 - $100.5 $15,051 - $19,899	-198 Reduced 0.57%	34,310 $2.79 Million
Q4 2020 Feb 12, 2021	BUY	$80.74 - $97.7 $31,246 - $37,809	387 Added 1.13%	34,508 $3 Million
Q3 2020 Dec 10, 2020	SELL	$85.07 - $109.69 $4,763 - $6,142	-56 Reduced 0.16%	34,121 $3.06 Million
Q2 2020 Aug 10, 2020	SELL	$74.18 - $108.93 $6,676 - $9,803	-90 Reduced 0.26%	34,177 $3.55 Million
Q1 2020 May 18, 2020	BUY	$63.18 - $85.97 $8,150 - $11,090	129 Added 0.38%	34,267 $2.51 Million
Q4 2019 Feb 13, 2020	SELL	$73.04 - $95.72 $57,482 - $75,331	-787 Reduced 2.25%	34,138 $2.98 Million
Q3 2019 Nov 12, 2019	BUY	$72.82 - $86.52 $43,619 - $51,825	599 Added 1.75%	34,925 $2.59 Million
Q2 2019 Aug 14, 2019	SELL	$73.52 - $88.7 $11,028 - $13,305	-150 Reduced 0.44%	34,326 $2.92 Million
Q1 2019 Apr 23, 2019	BUY	$63.56 - $88.17 $13,411 - $18,603	211 Added 0.62%	34,476 $2.97 Million
Q1 2019 Apr 12, 2019	BUY	$63.56 - $88.17 $2.18 Million - $3.02 Million	34,265 New	34,265 $2.18 Million

Others Institutions Holding INCY

# of Institutions

643

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.5B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Mercer Global Advisors Inc with notifications on news.

Account

Mercer Global Advisors Inc Incyte Corp Transaction History